Search Results - "Funk, Markus"
-
1
SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
Published in Transfusion (Philadelphia, Pa.) (01-06-2020)“…KEY IDEAS Oral swabs, sputum, and blood samples from 18 asymptomatic and symptomatic patients with SARS‐CoV‐2 infection were examined using RT‐PCR testing in…”
Get full text
Journal Article -
2
Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)
Published in Transfusion medicine and hemotherapy (01-10-2021)“…Introduction: According to German legislation, reports of suspected serious adverse reactions (AR) associated with the donation of blood and its components are…”
Get full text
Journal Article -
3
Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment
Published in Transfusion medicine and hemotherapy (01-06-2023)“…Introduction: Regulatory activities aim to facilitate the safe use of novel therapeutics such as genetically engineered chimeric antigen receptor (CAR)-T…”
Get full text
Journal Article -
4
Interaction of COP1 and UVR8 regulates UV-B-induced photomorphogenesis and stress acclimation in Arabidopsis
Published in The EMBO journal (04-03-2009)“…The ultraviolet‐B (UV‐B) portion of the solar radiation functions as an environmental signal for which plants have evolved specific and sensitive UV‐B…”
Get full text
Journal Article -
5
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany
Published in The Lancet regional health. Europe (01-01-2022)“…Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients…”
Get full text
Journal Article -
6
Sulfur-Bridged BODIPY DYEmers
Published in Chemistry : a European journal (19-08-2013)“…Reactions of BODIPY monomers with sulfur nucleophiles and electrophiles result in the formation of new BODIPY dimers. Mono‐ and disulfur bridges are…”
Get full text
Journal Article -
7
Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom
Published in British journal of haematology (30-10-2024)“…Prevention of ABO-incompatible red cell transfusions (ABO-it) requires accurate donor and patient identification and correct application of processes for…”
Get full text
Journal Article -
8
A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data
Published in Vox sanguinis (01-09-2024)“…Background and Objectives Haemovigilance (HV) systems aim to improve transfusion outcomes in patients and donor safety. An important question for blood…”
Get full text
Journal Article -
9
Impact of hepatitis E virus testing on the safety of blood components in Germany – results of a simulation study
Published in Vox sanguinis (01-11-2018)“…Hepatitis E virus (HEV) infections may be acquired through transfusion of blood components. As transfusion‐transmitted infections mostly affect vulnerable…”
Get full text
Journal Article -
10
Cryptochirality in 2,2′-Coupled BODIPY DYEmers
Published in European journal of organic chemistry (01-08-2016)“…The two chromophores in 2,2′‐coupled BODIPY DYEmers are linearly arranged and possess a configurationally stable axis. Their successful enantiomeric resolution…”
Get full text
Journal Article -
11
The role of isoagglutinins in intravenous immunoglobulin-related hemolysis
Published in Transfusion (Philadelphia, Pa.) (01-07-2015)“…BACKGROUND Increased reporting of intravenous immunoglobulin (IVIG)‐related hemolytic reactions (HRs) triggered an investigation by the German and Swiss health…”
Get full text
Journal Article -
12
Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)
Published in Transfusion medicine and hemotherapy (01-07-2015)“…Background: To assess the impact of safety measures, we compared reporting rates of transfusion-related reactions before and after the implementation of six…”
Get full text
Journal Article -
13
Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review
Published in Transfusion medicine and hemotherapy (01-10-2018)“…Background: Benefits and risks of liberal and restrictive transfusion regimens are under on-going controversial discussion. This systematic review aimed at…”
Get full text
Journal Article -
14
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
Published in npj vaccines (05-07-2022)“…We present the long-term outcomes of 44 patients who developed cerebral venous sinus thrombosis after vaccination with the adenoviral vector ChAdOx1 nCoV-19…”
Get full text
Journal Article -
15
Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets
Published in Transfusion (Philadelphia, Pa.) (01-02-2012)“…BACKGROUND: Five cases of human immunodeficiency virus Type 1 (HIV‐1) RNA–positive blood donations are described that escaped detection by three different…”
Get full text
Journal Article -
16
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections
Published in Transfusion medicine and hemotherapy (01-05-2021)“…Background: The SARS-CoV-2 pandemic has challenged many of our current routine practices in the treatment and care of patients. Given the critical importance…”
Get full text
Journal Article -
17
Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions
Published in Transfusion (Philadelphia, Pa.) (01-09-2009)“…BACKGROUND: Mandatory nucleic acid test (NAT) blood screening was introduced in Germany in 1999 for hepatitis C virus (HCV) RNA and in 2004 for human…”
Get full text
Journal Article -
18
Safety monitoring of cell-based medicinal products (CBMPs)
Published in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (01-11-2015)“…Cell-based medicinal products (CBMPs), a category of advanced-therapy medicinal products (ATMPs), are authorised for the European market by the European…”
Get full text
Journal Article -
19
Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany
Published in Transfusion medicine and hemotherapy (01-01-2014)“…Background: Several publications describe HIV-1 RNA false-negative results or viral load underquantitation associated with Communauté Européenne(CE)-marked…”
Get full text
Journal Article -
20
Functional analysis of EID1, an F‐box protein involved in phytochrome A‐dependent light signal transduction
Published in The Plant journal : for cell and molecular biology (01-02-2006)“…Summary Empfindlicher im Dunkelroten Licht 1 (EID1) is an F‐box protein that functions as a negative regulator in phytochrome A (phyA)‐specific light…”
Get full text
Journal Article